A new petition at the Patent Trial and Appeal Board, IPR2026-00413, was filed on August 14, 2026, and names Luxottica of America Inc. in the proceeding caption. For patent practitioners tracking activity in the eyewear, retail, consumer products, or branded technology spaces, this is a matter worth watching as the record develops.

At this early stage, the publicly available docket information identifies the proceeding title, filing date, and PTAB docket number, but key details that practitioners will want—most notably the patent number being challenged, the full party alignment between petitioner and patent owner, and the specific invalidity grounds asserted under 35 U.S.C. §§ 102 and/or 103—will likely become clearer as the petition and accompanying papers are added to the docket.

That said, the filing itself is significant.

Luxottica of America Inc. has filed a new inter partes review proceeding at the Patent Trial and Appeal Board, opening another matter for practitioners tracking how major consumer-brand companies use PTAB challenges as part of broader patent defense strategy. The petition, docketed as IPR2026-00412 and filed on August 7, 2026, is now pending before the Board.

At this early stage, the PTAB docket entry identifies Luxottica of America Inc. in the case caption, but the publicly available case summary does not yet provide the full set of details practitioners will want to monitor closely, including the challenged patent number, the named patent owner, and the specific prior-art grounds asserted in the petition.

A new inter partes review, IPR2026-00376, was filed at the Patent Trial and Appeal Board on June 18, 2026, naming Luxottica of America Inc. in the proceeding. While the publicly available docket caption confirms the PTAB filing and the involvement of Luxottica, this is the kind of early-stage matter patent practitioners will want to watch closely as the petition, patent-at-issue, and asserted invalidity theories come into sharper focus.

At this stage, the key takeaway is that a petitioner has asked the PTAB to institute trial on one or more claims of a patent connected to Luxottica.